Case 1:20-cr-00330-PAE Document 400 Filed 10/31/21 Page1lof2
UNITED STATES DISTRICT COURT ane aay
SOUTHERN DISTRICT OF NEW YORK MICLMENT |

ELECTRONICALLY FILED
DOC #:
United States of America, DATE FILED: —_—~—_<__
—V—-
20-CR-330 (AJN)
Ghislaine Maxwell,
ORDER
Defendant.
ALISON J. NATHAN, District Judge:

The Court is in receipt of the Defendant’s motion under Federal Rule of Evidence 412,
Dkt. No. 378, and the Defendant’s motion in limine to exclude under Federal Rule of Evidence
702 and Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), Dkt. No. 386. The
issues raised in the two motions overlap significantly. The Court is required under Federal Rule
of Evidence 412 to conduct an in camera hearing. Fed. R. Evid. 412 (“Before admitting
evidence under this rule, the court must conduct an in camera hearing and give the victim and
parties a right to attend and be heard. Unless the court orders otherwise, the motion, related
materials, and the record of the hearing must remain under seal.). In addition, the Court has
determined it will conduct a Daubert hearing with respect to the Defendant’s motion under
Federal Rule of Evidence 702. Because of the overlap in the substance of the motions, the Court
will conduct the two proceedings back to back.

The Court previously set a tentative date for the Rule 412 Motion hearing as November 5,
2021. Dkt. No. 354. The Court is prepared to proceed with both hearings on that date.
Alternatively, the proceedings could be held on either the afternoon of November 9 or the
afternoon of November 10. The Government shall confer with its proposed expert regarding
availability for the Daubert hearing as well as with alleged victims who wish to attend and be

1
DOJ-OGR-00006027
